EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling

J Mol Cell Biol. 2020 Jul 3;12(6):477-480. doi: 10.1093/jmcb/mjaa008.

Affiliations

¹ Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ 08903, USA.
² Evestra, Inc., San Antonio, TX 78245, USA.
³ Laboratory for Structural Bioinformatics, Center for Biosystems Dynamics Research, RIKEN, Yokohama 230-0045, Japan.
⁴ Department of Obstertrics and Gynecology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Cell Line, Tumor
Cell Movement / drug effects
Humans
Leukemia Inhibitory Factor / metabolism*
Receptors, OSM-LIF / metabolism
STAT3 Transcription Factor / metabolism
Signal Transduction* / drug effects
Small Molecule Libraries / chemistry
Small Molecule Libraries / pharmacology*

Substances

Leukemia Inhibitory Factor
Receptors, OSM-LIF
STAT3 Transcription Factor
Small Molecule Libraries